Intelligence Platform
Patents
Browse 13 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11851481
Treatment of central nervous system disorders by intranasal administration of immunoglobul
granted patentUS 11224646
Intranasal delivery of a cyclic-di-nucleotide adjuvanted vaccine for tuberculosis
granted patentUS 10682310
Therapeutic compounds and formulations for intranasal delivery
granted patentUS 10543283
Intranasal administration of guanidinylated aminoglycosides
granted patentUS 9757468
Intranasal administration of guanidinylated aminoglycosides
granted patentUS 9592207
Intranasal administration of ketamine to treat depression
granted patentUS 9585935
Intranasal oxytocin treatment to improve schizophrenia
granted patentUS 9249424
Intranasal delivery of AAV encoding therapeutic enzymes to the central nervous system for
granted patentUS 8609088
Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment
granted patentUS 8518390
Treatment of stroke and other acute neural degenerative disorders via intranasal administr
granted patentUS 7641906
Intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus i
granted patentUS 7112332
Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysac
granted patentUS 6090368
Pharmaceutical compositions for intranasal spray administration of ketorolac tromethamine
expired